首页 > 最新文献

Malaysian Journal of Medical Sciences最新文献

英文 中文
Advancing Research on Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Scientometric Analysis. 推进 Proprotein Convertase Subtilisin/Kexin Type 9 抑制剂的研究:科学计量分析。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-01 Epub Date: 2024-08-27 DOI: 10.21315/mjms2024.31.4.2
Abdul Matin, Gul-E-Saba Chaudhry, Mohamad Nor Azra, Mohamad Gazali, Yik Sung Yeong, Tengku Sifzizul Tengku Muhammad

Atherosclerosis is characterised by the accumulation of fatty deposits and plaque as a result of a continuously high level of low-density lipoprotein cholesterol (LDL-C) in the blood. The primary objective of this research is to assess the current status of knowledge, research endeavours and developmental trajectories about proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in correlation with atherosclerosis treatment. Additionally, this study aims to compile bibliometric and scientometric investigations within this domain through rigorous scientometric analysis. Analysing the bibliometric landscape and global research trends associated with PCSK9 inhibitors can contribute valuable insights into comprehending atherosclerosis. This is exemplified by examining publications within the Web of Science Core Collection (WOSCC) database from 2008 to 2022. Citespace was used for frequency, co-occurrence, co-citation, grouping and burst analysis, and Microsoft Excel was used to manage descriptive datasets. Eight hundred eighty-five publications available from WOSCC database between the years 2008 and 2022 were extracted and examined. Over the period, 3,138 collaborating institutions from 87 countries, a staggering 7,750 writers involved and 325 distinct journals published about PCSK9 inhibitors studies. Among authors, Sabatine et al. and the journal The New England Journal of Medicine has had the most significant impact. Lipid-lowering therapy and bempedoic acid are the most prominent topical clusters associated with PCSK9 inhibitors, and the most often used keywords are efficacy, safety and PCSK9 inhibitors. We believe this is the first comprehensive analysis of PCSK9 inhibitors research and publications conducted using Scientometric. These results demonstrate the nascence of PCSK9 inhibitors research. They may encourage a wide range of stakeholders, particularly early career researchers from various disciplines, to work together in the future.

动脉粥样硬化的特征是血液中低密度脂蛋白胆固醇(LDL-C)水平持续升高导致脂肪沉积和斑块堆积。本研究的主要目的是评估与动脉粥样硬化治疗相关的9型丙蛋白转换酶亚基酶/kexin(PCSK9)抑制剂的知识现状、研究工作和发展轨迹。此外,本研究旨在通过严格的科学计量学分析,汇编该领域的文献计量学和科学计量学调查。分析与 PCSK9 抑制剂相关的文献计量学概况和全球研究趋势有助于深入了解动脉粥样硬化。通过研究 2008 年至 2022 年科学网核心数据库(WOSCC)中的出版物,我们可以发现这一点。Citespace 用于频率、共现、共引、分组和突发分析,Microsoft Excel 用于管理描述性数据集。研究人员从世界学术会议数据库中提取并研究了2008年至2022年期间的885篇论文。在此期间,87个国家的3138家合作机构、7750名作者和325种不同期刊发表了有关PCSK9抑制剂研究的论文。在作者中,Sabatine 等人和《新英格兰医学杂志》杂志的影响最大。降脂疗法和贝母多酸是与 PCSK9 抑制剂相关的最突出的专题集群,最常使用的关键词是疗效、安全性和 PCSK9 抑制剂。我们认为,这是首次使用 Scientometric 对 PCSK9 抑制剂的研究和出版物进行全面分析。这些结果证明了 PCSK9 抑制剂研究的新生。它们可能会鼓励广泛的利益相关者,尤其是来自不同学科的早期职业研究人员在未来携手合作。
{"title":"Advancing Research on Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Scientometric Analysis.","authors":"Abdul Matin, Gul-E-Saba Chaudhry, Mohamad Nor Azra, Mohamad Gazali, Yik Sung Yeong, Tengku Sifzizul Tengku Muhammad","doi":"10.21315/mjms2024.31.4.2","DOIUrl":"10.21315/mjms2024.31.4.2","url":null,"abstract":"<p><p>Atherosclerosis is characterised by the accumulation of fatty deposits and plaque as a result of a continuously high level of low-density lipoprotein cholesterol (LDL-C) in the blood. The primary objective of this research is to assess the current status of knowledge, research endeavours and developmental trajectories about proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in correlation with atherosclerosis treatment. Additionally, this study aims to compile bibliometric and scientometric investigations within this domain through rigorous scientometric analysis. Analysing the bibliometric landscape and global research trends associated with PCSK9 inhibitors can contribute valuable insights into comprehending atherosclerosis. This is exemplified by examining publications within the Web of Science Core Collection (WOSCC) database from 2008 to 2022. Citespace was used for frequency, co-occurrence, co-citation, grouping and burst analysis, and Microsoft Excel was used to manage descriptive datasets. Eight hundred eighty-five publications available from WOSCC database between the years 2008 and 2022 were extracted and examined. Over the period, 3,138 collaborating institutions from 87 countries, a staggering 7,750 writers involved and 325 distinct journals published about PCSK9 inhibitors studies. Among authors, Sabatine et al. and the journal <i>The New England Journal of Medicine</i> has had the most significant impact. Lipid-lowering therapy and bempedoic acid are the most prominent topical clusters associated with PCSK9 inhibitors, and the most often used keywords are efficacy, safety and PCSK9 inhibitors. We believe this is the first comprehensive analysis of PCSK9 inhibitors research and publications conducted using Scientometric. These results demonstrate the nascence of PCSK9 inhibitors research. They may encourage a wide range of stakeholders, particularly early career researchers from various disciplines, to work together in the future.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"31 4","pages":"14-34"},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11377008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal Framework and Biological Indicators of Non-Suicidal Self-Injury and Related Behaviours. 非自杀性自伤及相关行为的时间框架和生物学指标。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-01 Epub Date: 2024-08-27 DOI: 10.21315/mjms2024.31.4.18
Uzma Ilyas, Ayera Butt, Khurram Awan, Javeria Asim, Muhammad Suleman Shakoor, Muqadas Fatima

Adolescence is a transitional stage between puberty and maturity. Significant alterations in brain chemistry and hormone activity cause mood swings and other psychological and physical symptoms. On their journey to adolescence, adolescents deal with complex emotions, moral dilemmas, sexual concerns, identity crises and particular societal expectations related to their upbringing. Impulsivity in adolescents is frequent and causes multiple issues. Impulsivity often lead towards non-suicidal self-injury (NSSI), which has devastating consequences, which are both physical and mental. Both impulsivity and NSSI have their roots in brain chemistry and its related functions. The aim of this special communication was to delve into brain chemistry through studying the function of neurotransmitters and brain areas in NSSI and impulsivity. Multiple papers were sought on the topic of neurochemistry and neuroanatomy. The results identified serotonin, dopamine and glutamate as the neurotransmitters responsible for NSSI and impulsivity. Dysregulation in these neurotransmitters lead to the presentation of NSSI and impulsivity. Other than the neurotransmitters, the brain areas identified were prefrontal cortex, medial prefrontal cortex and ventrolateral prefrontal cortex. The compiled results of this research would help individuals in understanding the neurotransmitters and the brain areas responsible. This would also help in generating awareness regarding the biological nature of the phenomenon as well, leading to less stigmatisation. The less stigmatisation towards these phenomena can help the affected individuals to seek help without any guilt or shame, along with support from society as well.

青春期是介于青春期和成熟期之间的过渡阶段。大脑化学和荷尔蒙活动的显著变化会导致情绪波动以及其他心理和生理症状。在青春期的旅途中,青少年要面对复杂的情绪、道德困境、性问题、身份危机以及与他们的成长经历有关的特殊社会期望。青少年的冲动行为很常见,会引发多种问题。冲动往往会导致非自杀性自残(NSSI),而非自杀性自残会对身心造成毁灭性的后果。冲动和非自杀性自伤都源于大脑化学及其相关功能。本特别通讯旨在通过研究神经递质和大脑区域在 NSSI 和冲动中的功能,深入探讨大脑化学。就神经化学和神经解剖学这一主题征集了多篇论文。结果发现,5-羟色胺、多巴胺和谷氨酸是导致 NSSI 和冲动的神经递质。这些神经递质的失调会导致 NSSI 和冲动的出现。除神经递质外,确定的大脑区域还有前额叶皮质、内侧前额叶皮质和外侧前额叶皮质。这项研究的汇总结果将有助于人们了解神经递质和负责的大脑区域。这也将有助于提高人们对这一现象的生物学性质的认识,从而减少鄙视。减少对这些现象的污名化可以帮助受影响的个人在没有任何内疚或羞耻感的情况下寻求帮助,同时还能得到社会的支持。
{"title":"Temporal Framework and Biological Indicators of Non-Suicidal Self-Injury and Related Behaviours.","authors":"Uzma Ilyas, Ayera Butt, Khurram Awan, Javeria Asim, Muhammad Suleman Shakoor, Muqadas Fatima","doi":"10.21315/mjms2024.31.4.18","DOIUrl":"10.21315/mjms2024.31.4.18","url":null,"abstract":"<p><p>Adolescence is a transitional stage between puberty and maturity. Significant alterations in brain chemistry and hormone activity cause mood swings and other psychological and physical symptoms. On their journey to adolescence, adolescents deal with complex emotions, moral dilemmas, sexual concerns, identity crises and particular societal expectations related to their upbringing. Impulsivity in adolescents is frequent and causes multiple issues. Impulsivity often lead towards non-suicidal self-injury (NSSI), which has devastating consequences, which are both physical and mental. Both impulsivity and NSSI have their roots in brain chemistry and its related functions. The aim of this special communication was to delve into brain chemistry through studying the function of neurotransmitters and brain areas in NSSI and impulsivity. Multiple papers were sought on the topic of neurochemistry and neuroanatomy. The results identified serotonin, dopamine and glutamate as the neurotransmitters responsible for NSSI and impulsivity. Dysregulation in these neurotransmitters lead to the presentation of NSSI and impulsivity. Other than the neurotransmitters, the brain areas identified were prefrontal cortex, medial prefrontal cortex and ventrolateral prefrontal cortex. The compiled results of this research would help individuals in understanding the neurotransmitters and the brain areas responsible. This would also help in generating awareness regarding the biological nature of the phenomenon as well, leading to less stigmatisation. The less stigmatisation towards these phenomena can help the affected individuals to seek help without any guilt or shame, along with support from society as well.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"31 4","pages":"218-222"},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11377006/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ameliorative Effects of Thymoquinone against Chemotherapy-Induced Testicular Damage in Experimental Animals: A Systematic Review. 胸腺醌对实验动物化疗所致睾丸损伤的改善作用:系统回顾
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-01 Epub Date: 2024-08-27 DOI: 10.21315/mjms2024.31.4.3
Sukinah A Tarmookh, Amal Ahmed El-Sheikh, Kamaluddin H Motawei, Khulood Mohammed Al-Khater, Sujatha Banglore, Rashid A Aldahhan

Chemotherapeutic drugs have demonstrated effectiveness in treating various neoplastic conditions; however, they can also have detrimental effects on male gonadal function and fertility. Consequently, interest has grown in identifying novel approaches that can mitigate chemotherapy-induced testicular damage. Thymoquinone (TQ), the chief active component of the volatile oil of Nigella sativa (NS), has a wide range of therapeutic properties, including antioxidant, anti-inflammatory and anti-apoptotic effects. The aim of this systematic review was to identify experimental animal studies that have evaluated the protective effects of TQ against testicular complications associated with chemotherapy. In accordance with the preferred reporting items for systematic review and meta-analyses (PRISMA) guidelines, a thorough search was performed across several databases (PubMed, EBSCOhost, Sage and Scopus) to identify experimental studies published from 2010 to May 2022 that focused on rodent models and compared the effects of TQ versus other chemotherapeutic drugs. Eight studies met the inclusion criteria, comparing TQ with methotrexate (MTX), 6-mercaptopurine (6-MP), cyclophosphamide (CPA), bleomycin (BL), doxorubicin (DOX) or busulfan (BUS). The results of these studies consistently demonstrated that TQ significantly improved sperm parameters, the levels of oxidative stress (OS) markers, apoptosis markers, and hormones and testicular histopathology, indicating that TQ has protective effects against chemotherapy-induced damage. TQ mitigated chemotherapy-induced testicular toxicity by decreasing lipid peroxidation and enhancing the activity of antioxidant enzymes within chemotherapy-treated testes. These findings highlight the potential of TQ as a therapeutic agent that can ameliorate testicular complications associated with chemotherapy, thereby providing a basis for further research and potential therapeutic applications.

化疗药物在治疗各种肿瘤疾病方面效果显著,但也会对男性性腺功能和生育能力产生不利影响。因此,人们越来越关注寻找新的方法来减轻化疗引起的睾丸损伤。胸腺醌(TQ)是黑升麻(NS)挥发油的主要活性成分,具有广泛的治疗特性,包括抗氧化、抗炎和抗细胞凋亡作用。本系统性综述的目的是确定评估 TQ 对化疗相关睾丸并发症保护作用的动物实验研究。根据系统综述和荟萃分析(PRISMA)指南的首选报告项目,我们在多个数据库(PubMed、EBSCOhost、Sage 和 Scopus)中进行了全面检索,以确定 2010 年至 2022 年 5 月期间发表的实验研究,这些研究侧重于啮齿动物模型,并比较了 TQ 与其他化疗药物的效果。八项研究符合纳入标准,将 TQ 与甲氨蝶呤 (MTX)、6-巯基嘌呤 (6-MP)、环磷酰胺 (CPA)、博来霉素 (BL)、多柔比星 (DOX) 或丁胺硫醇 (BUS) 进行了比较。这些研究结果一致表明,TQ能明显改善精子参数、氧化应激(OS)标志物、细胞凋亡标志物、激素水平和睾丸组织病理学,表明TQ对化疗引起的损伤具有保护作用。TQ通过降低化疗睾丸内的脂质过氧化反应和提高抗氧化酶的活性,减轻了化疗引起的睾丸毒性。这些发现凸显了 TQ 作为一种治疗剂的潜力,它可以改善化疗引起的睾丸并发症,从而为进一步的研究和潜在的治疗应用提供了基础。
{"title":"Ameliorative Effects of Thymoquinone against Chemotherapy-Induced Testicular Damage in Experimental Animals: A Systematic Review.","authors":"Sukinah A Tarmookh, Amal Ahmed El-Sheikh, Kamaluddin H Motawei, Khulood Mohammed Al-Khater, Sujatha Banglore, Rashid A Aldahhan","doi":"10.21315/mjms2024.31.4.3","DOIUrl":"10.21315/mjms2024.31.4.3","url":null,"abstract":"<p><p>Chemotherapeutic drugs have demonstrated effectiveness in treating various neoplastic conditions; however, they can also have detrimental effects on male gonadal function and fertility. Consequently, interest has grown in identifying novel approaches that can mitigate chemotherapy-induced testicular damage. Thymoquinone (TQ), the chief active component of the volatile oil of <i>Nigella sativa</i> (NS), has a wide range of therapeutic properties, including antioxidant, anti-inflammatory and anti-apoptotic effects. The aim of this systematic review was to identify experimental animal studies that have evaluated the protective effects of TQ against testicular complications associated with chemotherapy. In accordance with the preferred reporting items for systematic review and meta-analyses (PRISMA) guidelines, a thorough search was performed across several databases (PubMed, EBSCOhost, Sage and Scopus) to identify experimental studies published from 2010 to May 2022 that focused on rodent models and compared the effects of TQ versus other chemotherapeutic drugs. Eight studies met the inclusion criteria, comparing TQ with methotrexate (MTX), 6-mercaptopurine (6-MP), cyclophosphamide (CPA), bleomycin (BL), doxorubicin (DOX) or busulfan (BUS). The results of these studies consistently demonstrated that TQ significantly improved sperm parameters, the levels of oxidative stress (OS) markers, apoptosis markers, and hormones and testicular histopathology, indicating that TQ has protective effects against chemotherapy-induced damage. TQ mitigated chemotherapy-induced testicular toxicity by decreasing lipid peroxidation and enhancing the activity of antioxidant enzymes within chemotherapy-treated testes. These findings highlight the potential of TQ as a therapeutic agent that can ameliorate testicular complications associated with chemotherapy, thereby providing a basis for further research and potential therapeutic applications.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"31 4","pages":"35-49"},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11377007/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the Potential of Prostate-Specific Membrane Antigen for Precision Diagnosis and Therapy of Prostate Cancer: A Radiopharmaceutical Perspective. 揭示前列腺特异性膜抗原在前列腺癌精准诊断和治疗中的潜力:放射性药物视角。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-01 Epub Date: 2024-08-27 DOI: 10.21315/mjms2024.31.4.17
Hishar Hassan, Muhamad Faiz Othman, Zarif Naim Ashhar, Hairil Rashmizal Abdul Razak, Fathinul Fikri Ahmad Saad

Prostate-specific membrane antigen (PSMA) has proven to be an important target for diagnostic imaging in prostate cancer. As PSMA is overexpressed on the surface of prostate cancer cells, numerous targeted PSMA ligands have been developed. The emergence of PSMA targeting based on small molecules, such as the PSMA-11 ligand (or PSMA-HBED-CC), has led to breakthroughs, such as [68Ga]Ga-PSMA-11, for positron emission tomography (PET) imaging of biochemically recurrent or metastatic castration-resistant prostate cancer (mCRPC). In addition, the recent approval of [177Lu]Lu-PSMA-617 for the treatment of adult patients with PSMA-positive mCRPC represents an important milestone in prostate cancer therapy. These advances underscore the growing confidence in the use of PSMA-targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancer patients. PSMA-targeted radiopharmaceuticals have been shown to significantly impact treatment planning and clinical decision-making and facilitate the customisation of treatment regimens.

前列腺特异性膜抗原(PSMA)已被证明是前列腺癌诊断成像的一个重要靶点。由于 PSMA 在前列腺癌细胞表面过度表达,因此开发了许多 PSMA 靶向配体。以 PSMA-11 配体(或 PSMA-HBED-CC)等小分子为基础的 PSMA 靶向技术的出现带来了突破性进展,如 [68Ga]Ga-PSMA-11 可用于生化复发性或转移性去势抵抗性前列腺癌(mCRPC)的正电子发射断层扫描(PET)成像。此外,[177Lu]Lu-PSMA-617 最近被批准用于治疗 PSMA 阳性的 mCRPC 成年患者,这是前列腺癌治疗领域的一个重要里程碑。这些进展凸显了人们对使用 PSMA 靶向放射性药物诊断和治疗前列腺癌患者的信心与日俱增。事实证明,PSMA靶向放射性药物对治疗计划和临床决策有显著影响,并有助于定制治疗方案。
{"title":"Unveiling the Potential of Prostate-Specific Membrane Antigen for Precision Diagnosis and Therapy of Prostate Cancer: A Radiopharmaceutical Perspective.","authors":"Hishar Hassan, Muhamad Faiz Othman, Zarif Naim Ashhar, Hairil Rashmizal Abdul Razak, Fathinul Fikri Ahmad Saad","doi":"10.21315/mjms2024.31.4.17","DOIUrl":"10.21315/mjms2024.31.4.17","url":null,"abstract":"<p><p>Prostate-specific membrane antigen (PSMA) has proven to be an important target for diagnostic imaging in prostate cancer. As PSMA is overexpressed on the surface of prostate cancer cells, numerous targeted PSMA ligands have been developed. The emergence of PSMA targeting based on small molecules, such as the PSMA-11 ligand (or PSMA-HBED-CC), has led to breakthroughs, such as [<sup>68</sup>Ga]Ga-PSMA-11, for positron emission tomography (PET) imaging of biochemically recurrent or metastatic castration-resistant prostate cancer (mCRPC). In addition, the recent approval of [<sup>177</sup>Lu]Lu-PSMA-617 for the treatment of adult patients with PSMA-positive mCRPC represents an important milestone in prostate cancer therapy. These advances underscore the growing confidence in the use of PSMA-targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancer patients. PSMA-targeted radiopharmaceuticals have been shown to significantly impact treatment planning and clinical decision-making and facilitate the customisation of treatment regimens.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"31 4","pages":"213-217"},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11377010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of the Stroke e-Learning Module on Malaysian Doctors' Knowledge of Acute Ischaemic Stroke Management. 中风电子学习模块对马来西亚医生掌握急性缺血性中风管理知识的效果。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-01 Epub Date: 2024-08-27 DOI: 10.21315/mjms2024.31.4.16
Stephenie Ann Albart, Abdul Hanif Khan Yusof Khan, Aneesa Abdul Rashid, Wan Asyraf Wan Zaidi, Irene Looi, Fan Kee Hoo

Background: The Stroke e-Learning Module (SEM) is a nationwide initiative to improve stroke care in Malaysia. This study aimed to assess the module's effectiveness in improving knowledge on acute ischaemic stroke (AIS) management among Malaysian doctors.

Methods: This was a pre-post study design. Medical officers, specialists and general practitioners from various disciplines who work in healthcare facilities in Malaysia were recruited virtually from those who registered for the SEM on the Docquity platform between 1 February 2021 and 31 January 2022. The Acute Stroke Management Questionnaire (ASMaQ), an existing validated questionnaire, was used to measure the doctors' knowledge of AIS management before and after the SEM. The ASMaQ had three domains: i) general stroke knowledge (GSK), ii) hyperacute stroke management (HSM) and iii) advanced stroke management (ASM). The paired t- and the McNemar-tests were used to evaluate the effectiveness of the module.

Results: One hundred and seventy-one participants voluntarily responded to the pre- and post-module questionnaires. The paired t-test revealed statistically significant improvement for the ASM knowledge scores (mean difference = 2.5; 95% CI: 1.8, 3.2; P < 0.001). The baseline proportion of participants with good knowledge of GSK, HSM and ASM were 92.4%, 64.9%, and 76%, respectively. The McNemar test showed that approximately 14% of the participants had significant improvement in ASM knowledge (P < 0.001). However, no significant changes were noted for GSK (-0.6%) and HSM (4.1%).

Conclusion: The SEM has been shown to increase Malaysian doctors' knowledge on ASM. However, greater effort should be made to improve GSK and HSM knowledge, particularly in areas related to stroke thrombolysis.

背景:中风电子学习模块(SEM)是一项旨在改善马来西亚中风护理的全国性计划。本研究旨在评估该模块在提高马来西亚医生急性缺血性中风(AIS)管理知识方面的有效性:方法:这是一项前-后研究设计。从 2021 年 2 月 1 日至 2022 年 1 月 31 日期间在 Docquity 平台注册 SEM 的人员中虚拟招募了在马来西亚医疗机构工作的不同学科的医务人员、专科医生和全科医生。急性中风管理问卷(ASMaQ)是一份现有的经过验证的问卷,用于测量医生在 SEM 前后对急性中风管理知识的掌握情况。ASMaQ 包括三个方面:i) 一般卒中知识 (GSK),ii) 超急性卒中管理 (HSM) 和 iii) 高级卒中管理 (ASM)。采用配对 t 检验和 McNemar 检验来评估模块的有效性:结果:171 名参与者自愿回答了模块前后的问卷。配对 t 检验显示,ASM 知识得分有了显著提高(平均差异 = 2.5;95% CI:1.8,3.2;P <0.001)。对 GSK、HSM 和 ASM 有良好了解的参与者基线比例分别为 92.4%、64.9% 和 76%。McNemar 检验显示,约有 14% 的参与者在 ASM 知识方面有显著提高(P < 0.001)。然而,GSK(-0.6%)和 HSM(4.1%)没有明显变化:SEM已被证明能增加马来西亚医生的ASM知识。结论:事实表明,SEM 提高了马来西亚医生对 ASM 的认识,但应加大力度提高 GSK 和 HSM 的认识,尤其是在与中风溶栓相关的领域。
{"title":"Effectiveness of the Stroke e-Learning Module on Malaysian Doctors' Knowledge of Acute Ischaemic Stroke Management.","authors":"Stephenie Ann Albart, Abdul Hanif Khan Yusof Khan, Aneesa Abdul Rashid, Wan Asyraf Wan Zaidi, Irene Looi, Fan Kee Hoo","doi":"10.21315/mjms2024.31.4.16","DOIUrl":"10.21315/mjms2024.31.4.16","url":null,"abstract":"<p><strong>Background: </strong>The Stroke e-Learning Module (SEM) is a nationwide initiative to improve stroke care in Malaysia. This study aimed to assess the module's effectiveness in improving knowledge on acute ischaemic stroke (AIS) management among Malaysian doctors.</p><p><strong>Methods: </strong>This was a pre-post study design. Medical officers, specialists and general practitioners from various disciplines who work in healthcare facilities in Malaysia were recruited virtually from those who registered for the SEM on the Docquity platform between 1 February 2021 and 31 January 2022. The Acute Stroke Management Questionnaire (ASMaQ), an existing validated questionnaire, was used to measure the doctors' knowledge of AIS management before and after the SEM. The ASMaQ had three domains: i) general stroke knowledge (GSK), ii) hyperacute stroke management (HSM) and iii) advanced stroke management (ASM). The paired <i>t-</i> and the McNemar-tests were used to evaluate the effectiveness of the module.</p><p><strong>Results: </strong>One hundred and seventy-one participants voluntarily responded to the pre- and post-module questionnaires. The paired <i>t-</i>test revealed statistically significant improvement for the ASM knowledge scores (mean difference = 2.5; 95% CI: 1.8, 3.2; <i>P</i> < 0.001). The baseline proportion of participants with good knowledge of GSK, HSM and ASM were 92.4%, 64.9%, and 76%, respectively. The McNemar test showed that approximately 14% of the participants had significant improvement in ASM knowledge (<i>P</i> < 0.001). However, no significant changes were noted for GSK (-0.6%) and HSM (4.1%).</p><p><strong>Conclusion: </strong>The SEM has been shown to increase Malaysian doctors' knowledge on ASM. However, greater effort should be made to improve GSK and HSM knowledge, particularly in areas related to stroke thrombolysis.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"31 4","pages":"195-212"},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11377012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diffusion Magnetic Resonance Imaging and Human Reward System Research: A Bibliometric Analysis and Visualisation of Current Research Trends. 扩散磁共振成像与人类奖赏系统研究:当前研究趋势的文献计量分析与可视化》。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-01 Epub Date: 2024-08-27 DOI: 10.21315/mjms2024.31.4.9
Asma Hayati Ahmad, Siti Hajar Zabri, Siti Mariam Roslan, Nur Ayunie Ayob, Aini Ismafairus Abd Hamid, Nur Hartini Mohd Taib, Nasibah Mohamad, Zahiruddin Othman, Sofina Tamam, Aleya Aziz Marzuki, Rahimah Zakaria

Background: The human reward system has been extensively studied using neuroimaging. This bibliometric analysis aimed to determine the global trend in diffusion magnetic resonance imaging (dMRI) and human reward research in terms of the number of documents, the most active countries and their collaborating countries, the top journals and institutions, the most prominent authors and most cited articles, and research hotspots.

Methods: The research datasets were acquired from the Scopus database. The search terms used were 'reward' AND 'human' AND 'diffusion imaging' OR 'diffusion tensor imaging' OR 'diffusion MRI' OR 'diffusion-weighted imaging' OR 'tractography' in the abstract, article title and keywords. A total of 336 publications were analysed using Harzing's Publish or Perish and VOSviewer software.

Results: The results revealed an upward trend in the number of publications with the highest number of articles in 2020 and 2022. Most publications were limited to countries, authors, and institutions in the USA, China and Europe. Bracht, Coenen, Wiest, Federspiel and Feng were among the top authors from Switzerland, Germany and the UK. Neuroimage, Neuroimage Clinical, Frontiers in Human Neuroscience, Human Brain Mapping, and the Journal of Neuroscience were the top journals. Among the top articles, six were reviews and four were original articles, while the top keywords in human reward research were 'diffusion MRI', 'adolescence', 'depression' and 'reward-related brain areas'.

Conclusion: These findings may serve as researchers' references to find collaborative authors, relevant journals, cooperative countries/institutions, and hot topics related to dMRI and reward research.

背景:利用神经影像学对人类奖赏系统进行了广泛研究。这项文献计量分析旨在从文献数量、最活跃的国家及其合作国家、顶级期刊和机构、最著名的作者和被引用次数最多的文章以及研究热点等方面确定扩散磁共振成像(dMRI)和人类奖赏研究的全球趋势:研究数据集来自 Scopus 数据库。检索词包括摘要、文章标题和关键词中的 "奖励"、"人类"、"扩散成像 "或 "扩散张量成像 "或 "扩散 MRI "或 "扩散加权成像 "或 "牵引成像"。使用 Harzing's Publish or Perish 和 VOSviewer 软件对总共 336 篇论文进行了分析:结果显示,论文数量呈上升趋势,其中 2020 年和 2022 年的论文数量最多。大多数出版物仅限于美国、中国和欧洲的国家、作者和机构。Bracht、Coenen、Wiest、Federspiel和Feng是来自瑞士、德国和英国的顶尖作者。神经影像》、《神经影像临床》、《人类神经科学前沿》、《人类脑图谱》和《神经科学杂志》是排名最高的期刊。在排名靠前的文章中,有六篇是综述,四篇是原创文章,而人类奖赏研究的热门关键词是 "弥散核磁共振成像"、"青春期"、"抑郁症 "和 "奖赏相关脑区":这些发现可作为研究人员寻找与 dMRI 和奖赏研究相关的合作作者、相关期刊、合作国家/机构和热点话题的参考。
{"title":"Diffusion Magnetic Resonance Imaging and Human Reward System Research: A Bibliometric Analysis and Visualisation of Current Research Trends.","authors":"Asma Hayati Ahmad, Siti Hajar Zabri, Siti Mariam Roslan, Nur Ayunie Ayob, Aini Ismafairus Abd Hamid, Nur Hartini Mohd Taib, Nasibah Mohamad, Zahiruddin Othman, Sofina Tamam, Aleya Aziz Marzuki, Rahimah Zakaria","doi":"10.21315/mjms2024.31.4.9","DOIUrl":"10.21315/mjms2024.31.4.9","url":null,"abstract":"<p><strong>Background: </strong>The human reward system has been extensively studied using neuroimaging. This bibliometric analysis aimed to determine the global trend in diffusion magnetic resonance imaging (dMRI) and human reward research in terms of the number of documents, the most active countries and their collaborating countries, the top journals and institutions, the most prominent authors and most cited articles, and research hotspots.</p><p><strong>Methods: </strong>The research datasets were acquired from the Scopus database. The search terms used were 'reward' AND 'human' AND 'diffusion imaging' OR 'diffusion tensor imaging' OR 'diffusion MRI' OR 'diffusion-weighted imaging' OR 'tractography' in the abstract, article title and keywords. A total of 336 publications were analysed using Harzing's Publish or Perish and VOSviewer software.</p><p><strong>Results: </strong>The results revealed an upward trend in the number of publications with the highest number of articles in 2020 and 2022. Most publications were limited to countries, authors, and institutions in the USA, China and Europe. Bracht, Coenen, Wiest, Federspiel and Feng were among the top authors from Switzerland, Germany and the UK. <i>Neuroimage</i>, <i>Neuroimage Clinical, Frontiers in Human Neuroscience, Human Brain Mapping</i>, and the <i>Journal of Neuroscience</i> were the top journals. Among the top articles, six were reviews and four were original articles, while the top keywords in human reward research were 'diffusion MRI', 'adolescence', 'depression' and 'reward-related brain areas'.</p><p><strong>Conclusion: </strong>These findings may serve as researchers' references to find collaborative authors, relevant journals, cooperative countries/institutions, and hot topics related to dMRI and reward research.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"31 4","pages":"111-125"},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11377000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthy Ageing in Malaysia by 2030: Needs, Challenges and Future Directions. 2030 年马来西亚的健康老龄化:需求、挑战和未来方向。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-01 Epub Date: 2024-08-27 DOI: 10.21315/mjms2024.31.4.1
Jafri Malin Abdullah, Amin Ismail, Muhamad Saiful Bahri Yusoff

This Editorial addresses the critical need for developing a healthy ageing society in Malaysia by 2030. With the country's elderly population projected to increase significantly, the article explores current challenges, including healthcare disparities, a shortage of geriatric specialists and malnutrition. It evaluates existing policies and highlights successful international and local initiatives, suggesting specific recommendations to improve healthcare infrastructure, healthy ageing support and technological integration. Emphasising the importance of engaging private sectors, non-governmental organisations (NGOs) and community groups, this Editorial calls for a collaborative approach to address the economic and cultural aspects of ageing. This comprehensive strategy aims to ensure a resilient, healthy and inclusive environment for Malaysia's ageing population by 2030.

这篇社论探讨了马来西亚到 2030 年发展健康老龄化社会的迫切需要。随着马来西亚老年人口预计将大幅增加,文章探讨了当前面临的挑战,包括医疗保健差异、老年病专家短缺和营养不良。文章对现有政策进行了评估,并重点介绍了国际和本地的成功举措,提出了改善医疗基础设施、健康老龄化支持和技术整合的具体建议。该社论强调了私营部门、非政府组织和社区团体参与的重要性,呼吁采取合作方式解决老龄化的经济和文化问题。这一综合战略旨在确保到2030年为马来西亚的老龄人口提供一个有弹性、健康和包容的环境。
{"title":"Healthy Ageing in Malaysia by 2030: Needs, Challenges and Future Directions.","authors":"Jafri Malin Abdullah, Amin Ismail, Muhamad Saiful Bahri Yusoff","doi":"10.21315/mjms2024.31.4.1","DOIUrl":"10.21315/mjms2024.31.4.1","url":null,"abstract":"<p><p>This Editorial addresses the critical need for developing a healthy ageing society in Malaysia by 2030. With the country's elderly population projected to increase significantly, the article explores current challenges, including healthcare disparities, a shortage of geriatric specialists and malnutrition. It evaluates existing policies and highlights successful international and local initiatives, suggesting specific recommendations to improve healthcare infrastructure, healthy ageing support and technological integration. Emphasising the importance of engaging private sectors, non-governmental organisations (NGOs) and community groups, this Editorial calls for a collaborative approach to address the economic and cultural aspects of ageing. This comprehensive strategy aims to ensure a resilient, healthy and inclusive environment for Malaysia's ageing population by 2030.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"31 4","pages":"1-13"},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11376998/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of Congenital Toxoplasmosis and Cytomegalovirus Infections Using Paired Sample Serodiagnosis from Suspected Cases at a Tertiary Teaching Hospital in Malaysia. 马来西亚一家三级教学医院利用配对样本血清诊断法检测先天性弓形虫病和巨细胞病毒感染。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-01 Epub Date: 2024-08-27 DOI: 10.21315/mjms2024.31.4.8
Abdirahman Hussein Elmi, Ahmad Adebayo Irekeola, Muhammad Amiruddin Abdullah, Zeehaida Mohamed

Background: Congenital toxoplasmosis and congenital cytomegalovirus (cCMV) infections are noteworthy in Malaysia and can cause serious health problems in neonates. The prompt and effective detection and treatment related to both illnesses may mitigate the possibility of adverse consequences from both infections.

Methods: A total of 219 neonates with suspected clinical indications of congenital toxoplasmosis and/or cCMV infections from January 2022 to December 2022 were enrolled. The first samples for IgM and IgG antibodies were screened by electrochemiluminescence immunoassay. For positive results indicative of congenital toxoplasmosis and cCMV infections, second serum samples were requested and tested within a period of 2-4 weeks after testing the first sample.

Results: From the 219 first serum samples, the overall seroprevalence of congenital toxoplasmosis antibodies in suspected cases was 53%; meanwhile, the overall seroprevalence of cCMV in the suspected cases was 98.6%. The results of the paired serum sample collected for investigating congenital toxoplasmosis cases revealed that 47% of the cases presented no serological evidence of exposure while the remaining 53% of cases might have acquired passive immunity from the mother. For cCMV, the number of cases with no serological evidence of exposure was 1.4%, whereas acute infection was 1.8% and possible passive immunity from the mother represented 96.8%.

Conclusion: This study found a high seroprevalence of congenital toxoplasmosis and cCMV infections, probably because they are suspected cases. This study also indicates that using paired sample analysis in the categorisation of cases can aid in accurate diagnosis and more effective treatment.

背景:先天性弓形虫病和先天性巨细胞病毒(cCMV)感染在马来西亚很常见,可对新生儿造成严重的健康问题。对这两种疾病进行及时有效的检测和治疗可降低这两种感染造成不良后果的可能性:方法:2022 年 1 月至 2022 年 12 月期间,共有 219 名新生儿疑似患有先天性弓形虫病和/或 cCMV 感染。第一份样本通过电化学发光免疫分析法筛查 IgM 和 IgG 抗体。如果阳性结果表明患有先天性弓形虫病和 cCMV 感染,则要求检测第二份血清样本,并在检测第一份样本后的 2-4 周内进行检测:结果:在 219 份首次血清样本中,疑似病例中先天性弓形虫抗体的总血清阳性率为 53%;而疑似病例中 cCMV 的总血清阳性率为 98.6%。为调查先天性弓形虫病病例而采集的配对血清样本结果显示,47%的病例没有血清学证据表明接触过弓形虫,而其余 53%的病例可能从母亲那里获得了被动免疫。对于 cCMV,没有血清学证据表明接触过的病例占 1.4%,急性感染占 1.8%,可能从母亲那里获得被动免疫的占 96.8%:本研究发现先天性弓形虫病和 cCMV 感染的血清流行率很高,这可能是因为他们都是疑似病例。这项研究还表明,使用配对样本分析法对病例进行分类有助于准确诊断和更有效的治疗。
{"title":"Detection of Congenital Toxoplasmosis and Cytomegalovirus Infections Using Paired Sample Serodiagnosis from Suspected Cases at a Tertiary Teaching Hospital in Malaysia.","authors":"Abdirahman Hussein Elmi, Ahmad Adebayo Irekeola, Muhammad Amiruddin Abdullah, Zeehaida Mohamed","doi":"10.21315/mjms2024.31.4.8","DOIUrl":"10.21315/mjms2024.31.4.8","url":null,"abstract":"<p><strong>Background: </strong>Congenital toxoplasmosis and congenital cytomegalovirus (cCMV) infections are noteworthy in Malaysia and can cause serious health problems in neonates. The prompt and effective detection and treatment related to both illnesses may mitigate the possibility of adverse consequences from both infections.</p><p><strong>Methods: </strong>A total of 219 neonates with suspected clinical indications of congenital toxoplasmosis and/or cCMV infections from January 2022 to December 2022 were enrolled. The first samples for IgM and IgG antibodies were screened by electrochemiluminescence immunoassay. For positive results indicative of congenital toxoplasmosis and cCMV infections, second serum samples were requested and tested within a period of 2-4 weeks after testing the first sample.</p><p><strong>Results: </strong>From the 219 first serum samples, the overall seroprevalence of congenital toxoplasmosis antibodies in suspected cases was 53%; meanwhile, the overall seroprevalence of cCMV in the suspected cases was 98.6%. The results of the paired serum sample collected for investigating congenital toxoplasmosis cases revealed that 47% of the cases presented no serological evidence of exposure while the remaining 53% of cases might have acquired passive immunity from the mother. For cCMV, the number of cases with no serological evidence of exposure was 1.4%, whereas acute infection was 1.8% and possible passive immunity from the mother represented 96.8%.</p><p><strong>Conclusion: </strong>This study found a high seroprevalence of congenital toxoplasmosis and cCMV infections, probably because they are suspected cases. This study also indicates that using paired sample analysis in the categorisation of cases can aid in accurate diagnosis and more effective treatment.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"31 4","pages":"101-110"},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11377005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Upregulation of Serum miR-132 and miR-152 in Vietnamese Patients with Heart Failure. 越南心力衰竭患者血清 miR-132 和 miR-152 的上调。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-01 Epub Date: 2024-08-27 DOI: 10.21315/mjms2024.31.4.7
Diem My Vu, Anh Phuong Huynh, Nhu Nhat Quynh Nguyen, Niem Van Thanh Vo, An Bac Luong, Thanh Cong Nguyen, Anh Vu Hoang

Background: MicroRNAs (miRs) are emerging targets for the diagnosis, prognosis and treatment of heart failure (HF). Accumulated evidence showed that microRNA-132 (miR-132) and microRNA-152 (miR-152) play critical roles in the development of multiple pathological processes of the heart. Although their upregulations have been detected in the failing hearts of humans and animal models, little is known about the circulating levels of miR-132 and miR-152 in patients with HF.

Methods: Our study was conducted from January 2022 to August 2022 at the Cardiology Department of the University Medical Center in Ho Chi Minh City, Vietnam. During study period, 36 participants were consecutively enrolled, including 18 HF patients and 18 patients who age and sex matched the non-HF controls. Serum samples of study participants were collected on admission and the expression levels of miR-132 and miR-152 were measured by quantitative reverse transcription polymerase chain reaction (RT-PCR). The comparative cycle threshold method (ΔCt) was applied to calculate the relative expression of miRs.

Results: The miR concentration in HF group was significantly lower than that in the control group. In contrast, the serum levels of miR-132 and miR-152 were significantly higher in HF patients. Further analyses of receiver operating characteristic (ROC) curve showed that miR-132 and miR-152 individually had moderate diagnostic potential for HF (with area under curve [AUC] values of 0.713 and 0.698, respectively). A positive correlation between these miRs was also confirmed.

Conclusion: Serum miR-132 and miR-152 were upregulated in Vietnamese patients with HF and may serve as candidate biomarkers for diagnostic purposes.

背景:微RNA(miRs)是诊断、预后和治疗心力衰竭(HF)的新兴靶点。累积的证据表明,microRNA-132(miR-132)和microRNA-152(miR-152)在心脏多种病理过程的发展中起着关键作用。尽管在人类和动物模型的衰竭心脏中发现了它们的上调,但人们对高频患者体内循环中的 miR-132 和 miR-152 水平知之甚少:我们的研究于 2022 年 1 月至 2022 年 8 月在越南胡志明市大学医疗中心心脏病科进行。研究期间,连续招募了 36 名参与者,其中包括 18 名高血压患者和 18 名年龄和性别与非高血压对照组相匹配的患者。研究人员在入院时采集血清样本,并通过反转录聚合酶链反应(RT-PCR)定量检测 miR-132 和 miR-152 的表达水平。采用比较周期阈值法(ΔCt)计算miRs的相对表达量:结果:高血脂组的 miR 浓度明显低于对照组。相比之下,高血脂患者血清中的 miR-132 和 miR-152 水平明显较高。接收器操作特征曲线(ROC)的进一步分析表明,miR-132 和 miR-152 对心房颤动具有中等诊断潜力(曲线下面积[AUC]值分别为 0.713 和 0.698)。这些 miR 之间的正相关性也得到了证实:结论:越南心房颤动患者的血清 miR-132 和 miR-152 上调,可作为诊断目的的候选生物标志物。
{"title":"Upregulation of Serum miR-132 and miR-152 in Vietnamese Patients with Heart Failure.","authors":"Diem My Vu, Anh Phuong Huynh, Nhu Nhat Quynh Nguyen, Niem Van Thanh Vo, An Bac Luong, Thanh Cong Nguyen, Anh Vu Hoang","doi":"10.21315/mjms2024.31.4.7","DOIUrl":"10.21315/mjms2024.31.4.7","url":null,"abstract":"<p><strong>Background: </strong>MicroRNAs (miRs) are emerging targets for the diagnosis, prognosis and treatment of heart failure (HF). Accumulated evidence showed that microRNA-132 (miR-132) and microRNA-152 (miR-152) play critical roles in the development of multiple pathological processes of the heart. Although their upregulations have been detected in the failing hearts of humans and animal models, little is known about the circulating levels of miR-132 and miR-152 in patients with HF.</p><p><strong>Methods: </strong>Our study was conducted from January 2022 to August 2022 at the Cardiology Department of the University Medical Center in Ho Chi Minh City, Vietnam. During study period, 36 participants were consecutively enrolled, including 18 HF patients and 18 patients who age and sex matched the non-HF controls. Serum samples of study participants were collected on admission and the expression levels of miR-132 and miR-152 were measured by quantitative reverse transcription polymerase chain reaction (RT-PCR). The comparative cycle threshold method (ΔCt) was applied to calculate the relative expression of miRs.</p><p><strong>Results: </strong>The miR concentration in HF group was significantly lower than that in the control group. In contrast, the serum levels of miR-132 and miR-152 were significantly higher in HF patients. Further analyses of receiver operating characteristic (ROC) curve showed that miR-132 and miR-152 individually had moderate diagnostic potential for HF (with area under curve [AUC] values of 0.713 and 0.698, respectively). A positive correlation between these miRs was also confirmed.</p><p><strong>Conclusion: </strong>Serum miR-132 and miR-152 were upregulated in Vietnamese patients with HF and may serve as candidate biomarkers for diagnostic purposes.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"31 4","pages":"91-100"},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11377001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142157195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comorbidities and Monitoring in Patients with Chronic Hepatitis B on Nucleos(t)ide Analogues Attending a Tertiary Hospital in Malaysia, Southeast Asia: A Critical Perspective. 在东南亚马来西亚一家三甲医院就诊的使用核苷酸类似物的慢性乙型肝炎患者的并发症和监测:关键视角。
IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-08-01 Epub Date: 2024-08-27 DOI: 10.21315/mjms2024.31.4.12
Kizito Eneye Bello, Itodo Janefrancis Kelechi, Zakari A David, Adejo Patience Omebije, Rafidah Hanim Shueb, Nazri Mustaffa

Background: Chronic hepatitis B (CHB) is a significant global public health concern in Malaysia. It is a potentially life-threatening liver disease caused by the hepatitis B virus (HBV), which can lead to long-term complications such as cirrhosis, liver failure and hepatocellular carcinoma. In managing CHB, nucleos(t)ide analogues (NAs) have become the preferred treatment due to their ability to suppress viral replication and prevent disease progression. The question of liver-associated comorbidities related to patients with CHB on NAs remains unresolved in Malaysia despite the impending burden of CHB in the country. This study intends to address this and related aspects.

Method: We assessed 136 CHB patients on NAs in one centre, the Hospital Universiti Sains Malaysia. Demographic and epidemiological data on the treatment, concomitant disease and monitoring strategies were collected and analysed.

Result: Patients on NAs aged 50 years old-70 years old had the highest proportion of CHB (45.59%), with males representing 61.03% of that age group. There was a statistical significance in CHB acquisition and presence of comorbidities at P > 0.005. Our cohort displayed seven comorbidities (diabetes, obesity, rheumatoid diseases, renal impairment, spontaneous bacterial peritonitis, hypertension, non-hepatocellular malignancies and carcinoma); hypertension had the highest incidence (69.12%), while renal impairment had the lowest incidence (8.09%). Whole blood count, liver function and creatinine tests were the major monitoring tests used in over 90% of the cohort compared to viral load (6.1%).

Conclusion: Diabetes, hypertension and obesity were independent risk factors for acquiring liver cirrhosis and hepatocellular carcinoma. Malaysian CHB patients treated with NAs have several comorbidities that could affect disease outcomes. Therefore, careful monitoring is required.

背景:在马来西亚,慢性乙型肝炎(CHB)是一个重大的全球公共卫生问题。它是由乙型肝炎病毒(HBV)引起的一种可能危及生命的肝病,可导致肝硬化、肝衰竭和肝细胞癌等长期并发症。在治疗慢性乙型肝炎时,核苷(t)ide 类似物(NAs)因其抑制病毒复制和防止疾病进展的能力而成为首选治疗药物。尽管马来西亚的慢性阻塞性肺病负担日益沉重,但接受NAs治疗的慢性阻塞性肺病患者的肝脏相关并发症问题仍未得到解决。本研究旨在解决这一问题及相关方面的问题:方法:我们对马来西亚理科大学医院(Hospital Universiti Sains Malaysia)的136名接受新农合治疗的慢性阻塞性肺病患者进行了评估。我们收集并分析了有关治疗、伴随疾病和监测策略的人口统计学和流行病学数据:结果:50-70 岁的新农合患者中患慢性阻塞性肺病的比例最高(45.59%),男性占该年龄组的 61.03%。CHB的获得与合并症的存在有统计学意义(P > 0.005)。我们的队列中有七种合并症(糖尿病、肥胖、类风湿病、肾功能损害、自发性细菌性腹膜炎、高血压、非肝细胞恶性肿瘤和癌症);高血压的发病率最高(69.12%),而肾功能损害的发病率最低(8.09%)。与病毒载量(6.1%)相比,全血细胞计数、肝功能和肌酐检测是超过 90% 的队列中使用的主要监测检测项目:结论:糖尿病、高血压和肥胖是导致肝硬化和肝细胞癌的独立风险因素。接受NAs治疗的马来西亚慢性阻塞性肺病患者有多种合并症,这些合并症可能会影响疾病的治疗效果。因此,需要进行仔细监测。
{"title":"Comorbidities and Monitoring in Patients with Chronic Hepatitis B on Nucleos(t)ide Analogues Attending a Tertiary Hospital in Malaysia, Southeast Asia: A Critical Perspective.","authors":"Kizito Eneye Bello, Itodo Janefrancis Kelechi, Zakari A David, Adejo Patience Omebije, Rafidah Hanim Shueb, Nazri Mustaffa","doi":"10.21315/mjms2024.31.4.12","DOIUrl":"10.21315/mjms2024.31.4.12","url":null,"abstract":"<p><strong>Background: </strong>Chronic hepatitis B (CHB) is a significant global public health concern in Malaysia. It is a potentially life-threatening liver disease caused by the hepatitis B virus (HBV), which can lead to long-term complications such as cirrhosis, liver failure and hepatocellular carcinoma. In managing CHB, nucleos(t)ide analogues (NAs) have become the preferred treatment due to their ability to suppress viral replication and prevent disease progression. The question of liver-associated comorbidities related to patients with CHB on NAs remains unresolved in Malaysia despite the impending burden of CHB in the country. This study intends to address this and related aspects.</p><p><strong>Method: </strong>We assessed 136 CHB patients on NAs in one centre, the Hospital Universiti Sains Malaysia. Demographic and epidemiological data on the treatment, concomitant disease and monitoring strategies were collected and analysed.</p><p><strong>Result: </strong>Patients on NAs aged 50 years old-70 years old had the highest proportion of CHB (45.59%), with males representing 61.03% of that age group. There was a statistical significance in CHB acquisition and presence of comorbidities at <i>P ></i> 0.005. Our cohort displayed seven comorbidities (diabetes, obesity, rheumatoid diseases, renal impairment, spontaneous bacterial peritonitis, hypertension, non-hepatocellular malignancies and carcinoma); hypertension had the highest incidence (69.12%), while renal impairment had the lowest incidence (8.09%). Whole blood count, liver function and creatinine tests were the major monitoring tests used in over 90% of the cohort compared to viral load (6.1%).</p><p><strong>Conclusion: </strong>Diabetes, hypertension and obesity were independent risk factors for acquiring liver cirrhosis and hepatocellular carcinoma. Malaysian CHB patients treated with NAs have several comorbidities that could affect disease outcomes. Therefore, careful monitoring is required.</p>","PeriodicalId":47388,"journal":{"name":"Malaysian Journal of Medical Sciences","volume":"31 4","pages":"149-161"},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11376997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Malaysian Journal of Medical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1